Jintropin vials 10 IU, 1 ml, #5

Description

Jintropin vials 10 IU, 1 ml, #5 Solution

Composition

Each vial of Jintropin contains 10 IU (International Units) of the active ingredient, somatropin, which is a recombinant human growth hormone. The solution is supplied in a 1 mL volume. The box contains 5 vials.

Description

Jintropin is a synthetic form of human growth hormone, produced using recombinant DNA technology. It is used therapeutically to treat various health conditions related to growth hormone deficiency. Jintropin mimics the natural growth hormone in structure and function, thereby promoting cell growth, regeneration, and repair.

Indications

Jintropin is indicated for the treatment of growth failure due to inadequate secretion of endogenous growth hormone in pediatric patients. It is also used for the treatment of adults with either childhood-onset or adult-onset growth hormone deficiency.

Contraindications

Jintropin is contraindicated in patients with acute critical illnesses, patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment, and patients with active malignancy. It should not be used in patients with known hypersensitivity to somatropin or any of its excipients.

Administration and Dosage

Jintropin is administered subcutaneously. The dosage is individualized based on the patient’s weight, medical condition, and response to therapy. It is recommended to rotate the injection site to prevent skin lipoatrophy.

Side Effects

Common side effects of Jintropin include injection site reactions (pain, redness, or swelling), headache, muscle pain, and joint stiffness. More serious side effects include severe abdominal pain, changes in vision, increased thirst or urination, and rapid heartbeat.

Drug Interactions

Jintropin may interact with other medications, altering their effectiveness or increasing their side effects. These include corticosteroids, sex hormones, anticonvulsants, and insulin. Patients should inform their healthcare provider about all the medicines they take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Storage

Jintropin vials should be stored in a refrigerator (2°C to 8°C). Do not freeze. Vials should be kept in the original box to protect from light. Once reconstituted, the solution should be used immediately and any unused portion should be discarded.

Overdose

In case of overdose, immediate medical attention is required. Overdose may cause rapid heartbeat, shaking, or cold sweat. Long-term overdose may lead to excessive growth (gigantism) and metabolic changes.

Precautions

Patients should be monitored closely during treatment with Jintropin for any adverse reactions or changes in health condition. Regular follow-ups and laboratory tests are required to assess the therapy’s effectiveness and safety.

Warning

Jintropin should not be used in children with closed growth plates. It should be used with caution in patients with diabetes, as it may require adjustment of their antidiabetic treatment. It should also be used cautiously in elderly patients, as they may be more sensitive to its effects.

Disposal

Unused or expired Jintropin vials should be disposed of in accordance with local requirements. Do not flush down the toilet or pour them into a drain unless instructed to do so.

Pregnancy and Lactation

There is limited information about the use of Jintropin during pregnancy and lactation. Therefore, it should be used only if clearly needed and the potential benefits outweigh the potential risks.

Manufactured by

Jintropin is manufactured by GeneScience Pharmaceuticals Co., Ltd., a leading biopharmaceutical company specialized in human growth hormone research and development.